Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Spain
Rivastigmine

AEMPS 2007

Rivastigmine

EXELON 4,6 mg/24 H PARCHE TRANSDERMICO

4,6 mg parche transdérmicoSpainMarketedAuthorised 23 Oct 2007

Product informationAsk Osler about it

On this page

In other countries
Packs
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

Exelon Patch 10Canada · 9.5 MG / 24 HOUR · Patch · Knight Therapeutics INC.Same brand
Exelon Patch 15Canada · 13.3 MG / 24 HOUR · Patch · Knight Therapeutics INC.Same brand
Exelon Patch 5Canada · 4.6 MG / 24 HOUR · Patch · Knight Therapeutics INC.Same brand
ExelonEuropean Union · Novartis Europharm LimitedSame brand
ExelonCroatiaSame brand
ExelonItaly · Cerotto transdermico · Novartis Europharm LimitedSame brand
ExelonItaly · Capsula rigida · BB Farma S.R.L.Same brand

More with the same substance on this register

Alzerta 13,3 MG/24 H Parches Transdermicos EfgRivastigmine · 19,2 mg · parche transdérmicoSpain
Alzerta 4,6 MG/24 H Parches Transdermicos EfgRivastigmine · 6,9 mg · parche transdérmicoSpain

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Exelon 13,3 mg/24 uur, pleister voor transdermaal gebruikNetherlands · Pleister voor transdermaal gebruik · Novartis Europharm Limited

Same brand

🇳🇱Exelon 4,6 mg/24u, pleister voor transdermaal gebruikNetherlands · Pleister voor transdermaal gebruik · Novartis Europharm LimitedSame brand

🇳🇱Exelon 9,5 mg/24 u, pleister voor transdermaal gebruikNetherlands · Pleister voor transdermaal gebruik · Novartis Europharm LimitedSame brand

🇷🇴EXELON 13,3 mg/24hRomania · 13,3/24h · plasture transdermic · Novartis Europharm LimitedSame brand

🇷🇴EXELON 13.3mg/24hRomania · 13.3/24h · plasture transdermic · Novartis Europharm LTDSame brand

🇷🇴EXELON 13.3mg/24hRomania · 13.3 mg/24h · plasture transdermic · Novartis Europharm LimitedSame brand

🇷🇸Exelon®Serbia · 13.3mg/24h · transdermalni flaster · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand

🇷🇸Exelon®Serbia · 4.6mg/24h · transdermalni flaster · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand

🇷🇸Exelon®Serbia · 9.5mg/24h · transdermalni flaster · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand

🇸🇦Exelon 4.6MG-24H Transdermal PatchesSaudi Arabia · LTS LOHMANN Therapie-SystemeSame brand

🇸🇦Exelon 9.5MG-24H Transdermal PatchesSaudi Arabia · LTS LOHMANN Therapie-SystemeSame brand

🇸🇦EXELON 1.5 mg capsuleSaudi Arabia · Siegfried Barbera, S.LSame brand

🇸🇬Exelon Patch 10 (9.5mg/24hr)Singapore · 18.00mg/10cm2 · patch, extended release · Novartis (Singapore) Pte LTDSame brand

🇸🇬EXELON PATCH 15 (13.3mg/24hr)Singapore · 27.000 mg · patch, extended release · Novartis (Singapore) Pte LTDSame brand

🇸🇬Exelon Patch 5 (4.6mg/24hr)Singapore · 9mg/5cm2 · patch, extended release · Novartis (Singapore) Pte LTDSame brand

🇺🇸ExelonUnited States · 13.3MG/24HR, 4.6MG/24HR, 9.5MG/24HR · film, extended release · SandozSame brand

🇺🇸ExelonUnited States · 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · capsule · NovartisSame brand

🇺🇸ExelonUnited States · 2MG BASE/ML · solution · NovartisSame brand

🇧🇷Vivencia PatchBrazil · Aché Laboratórios Farmacêuticos S.ASame form

🇮🇹DemeloraItaly · Cerotto transdermico · Neuraxpharm Italy S.P.A.Same form

🇳🇿Rivastigmine Patch BNM 10New Zealand · Patch 9.5 mg per 24 hourSame form

🇳🇿Rivastigmine Patch BNM 5New Zealand · Patch 4.6 mg per 24 hourSame form

🇧🇷rivastigminaBrazil · Aché Laboratórios Farmacêuticos S.ASame substance

🇧🇷rivastigminaBrazil · Adium S.A.Same substance

🇪🇺NimvastidEuropean Union · Krka, d.d., Novo mestoSame substance

🇪🇺PrometaxEuropean Union · Almirall, S.A.Same substance

🇭🇷NimvastidCroatiaSame substance

🇭🇷PrometaxCroatiaSame substance

Packs

Pack	Code	Status
EXELON 4,6 mg/24 H PARCHE TRANSDERMICO, 30 parches	660037
EXELON 4,6 mg/24 H PARCHE TRANSDERMICO, 30 parches	728206
EXELON 4,6 mg/24 H PARCHE TRANSDERMICO, 60 (2 x 30) parches	728207

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS
Package leafletAEMPS
Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rivastigmine
Strength: 4,6 mg
Dosage form: parche transdérmico
Route: vía transdérmica
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 23 Oct 2007
Registration: 98066020
Marketing authorisation holder: Novartis Europharm Limited
Procedure: EU centralised
Supply: Diagnóstico Hospitalario

🇪🇸

AEMPSAlzerta 9,5 MG/24 H Parches Transdermicos EfgRivastigmine · 13,8 mg · parche transdérmico🇪🇸Spain

AEMPSAlzerta Dos Por Semana 4,6 MG/24 H Parches TransdermicosRivastigmine · 25,92 mg · parche transdérmico🇪🇸Spain

AEMPSAlzerta Dos Por Semana 9,5 MG/24 H Parches TransdermicosRivastigmine · 51,84 mg · parche transdérmico🇪🇸Spain

AEMPSEXELON 1,5 mg CAPSULAS DURASRivastigmine · 1,5 mg · cápsula dura🇪🇸Spain

AEMPSEXELON 1,5 mg CAPSULAS DURASRivastigmine · 1,5 mg · cápsula dura🇪🇸Spain

AEMPSEXELON 1,5 mg CAPSULAS DURASRivastigmine · 1,5 mg · cápsula dura🇪🇸Spain

AEMPSEXELON 13,3 mg/24 H PARCHE TRANSDERMICORivastigmine · 27 mg · parche transdérmico🇪🇸Spain

AEMPSEXELON 2 mg/ml SOLUCION ORALRivastigmine · 2 mg · solución oral🇪🇸Spain

AEMPSEXELON 3 mg CAPSULAS DURASRivastigmine · 3 mg · cápsula dura🇪🇸Spain

AEMPSEXELON 3 mg CAPSULAS DURASRivastigmine · 3 mg · cápsula dura🇪🇸Spain